glp 1 obesity GLP-1 Market GLP-1 Agonists: Using Semaglutide, Tirzepatide,
Description
M., Chun, S
Surgical Endoscopy, 38 (11), 65606565
they overlap with many other, more common conditions
GLP-1 Users Want Products to Meet Their Needs About one in three current users say they have come across products marketed specifically for GLP-1 users, and more than half of current users would be more likely to purchase some products if they catered specifically to those on GLP-1 medications
As mentioned above, 70% of diabetes patients discontinue GLP-1 treatment within two years
Alongside the relatively high cost of GLP-1 drugs in the U.S., there have been recent reports of shortages or limited availability of these drugs occurring as demand increases
